Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
5.38
↑ 328% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
-2.36
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.38 | +444.0% |
| 2024 | -1.56 | -381.8% |
| 2023 | -0.32 | +77.0% |
| 2022 | -1.41 | +66.6% |
| 2021 | -4.22 | -0.3% |
| 2020 | -4.21 | -54.5% |
| 2019 | -2.73 | +56.5% |
| 2018 | -6.27 | -63.8% |
| 2017 | -3.83 | +14.1% |
| 2016 | -4.45 | - |